Erlotinib-[d8]

Ask supplier a question | View on supplier's website

Erlotinib-[d8] is the labelled analogue of Erlotinib. Erlotinib is a tyrosine kinase inhibitor which acts on the epidermal growth factor receptor (EGFR), inhibiting EGFR-associated kinase activity. Erlotinib is a medication used to treat non-small cell lung cancer and pancreatic cancer.

Supplier	BOC Sciences
Product #	BLP-005332
Pricing	Inquire
Cas	1266534-68-2
Molecular Weight	401.49
Molecular Formula	C22H15D8N3O4

Feedback